Mark Kirschbaum is Chief Medical Officer of Cyclacel Pharmaceuticals, Inc.
Person profile
Latest filings (excl ownership)
No filings
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
30 Jun 23 | CYCC Cyclacel Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 0.5891 | 70,200 | 41.35 k | 70,200 |